JDRF welcomes TGA approval on Pfizer vaccine for children aged 12-15
JDRF Australia welcomes the announcement that the Therapeutic Goods Administration (TGA) has approved the Pfizer COVID-19 vaccine for children aged 12-15.
We look forward to the final decision from the Australian Technical Advisory Group on Immunisation (ATAGI) to prioritise children with underlying conditions, including type 1 diabetes, and include them immediately in the vaccine rollout.
COVID-19 is a particular concern for the type 1 diabetes community, and we applaud this new development for giving young people a way to protect themselves against the devastating effects of the disease.
Commenting on the announcement, JDRF Australia Chief Scientific Officer Dr Dorota Pawlak said “this is a great step forward for many families living with type 1 diabetes, offering young people an opportunity to protect themselves and others against COVID-19. We thank all the researchers, clinical trial participants and government groups who have made this new development possible.”
JDRF welcomes senior business leader Ian Narev to the JDRF Board
Mr Narev will bring more than 30 years of strategy and leadership experience garnered across consulting finance and technology businesses. JDRF Australia are delighted to welcome Ian Narev, Managing Director and Chief Executive Officer of SEEK to the Board. Mr Narev, who joined the Board at the September 2021 Board meeting, is no stranger to JDRF having spent several years as co-Chair of the JDRF Australia Advisory Board. Alongside his historical […]
Meet the inspiring father-daughter duo taking on the JDRF One Ride Challenge!
Let’s meet the inspiring father-daughter duo who share a passion for BMX riding and a goal to help defeat type 1 diabetes. Daniel was diagnosed with type 1 diabetes (T1D) at a young age, but that didn’t stop him from becoming a proud father of two, a motorcycle racer, and a mentor and supporter to […]
JDRF launches pilot study of general population screening for type 1 diabetes
Last year, JDRF appointed Dr Kirstine Bell from the Charles Perkins Centre, University of Sydney, to lead a pilot study to screen for risk of type 1 diabetes in the general population. Today, Dr Bell launched the national screening project and revealed new details about what it will involve. “Children are often diagnosed with type […]
COVID-19 Vaccines and T1D: Answering Your Questions
UPDATED 2 August 2021 Australia has begun the rollout of two COVID-19 vaccines — one from Pfizer, and one from AstraZeneca. Both these vaccines are safe and effective at protecting people against COVID-19, and all Australians are encouraged to get vaccinated. With vaccines now being offered to people with T1D, we’ve gathered all the information […]